Taysha Gene Therapies, Inc. TSHA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$129.88M-49.7% | -$109M-22.1% | -$99.93M— | -$92.72M— | -$86.77M— | ||
| $1.09M-7.8% | $1.08M-12.0% | $1.09M-15.8% | $1.19M-8.1% | $1.19M-14.7% | ||
| $15.55M+17.8% | $13.3M+1.5% | $12.99M+9.5% | $13.06M+23.9% | $13.2M+40.0% | ||
| -$111.95M-34.2% | -$93.09M-14.6% | -$84.68M-7.1% | -$82.13M-9.0% | -$83.45M-14.9% | ||
| $384K-37.5% | $738K+96.3% | $488K+24.2% | $415K— | $614K— | ||
| —— | —— | —— | —— | -$607K+83.3% | ||
| $275.35M+258% | $274.59M+256% | $225.03M+192% | $222.83M+5.6% | $77.01M-45.4% | ||
| $175.56M+2,477% | $196.31M+4,103% | $155.07M— | $140.02M— | -$7.39M— | ||
| -$112.33M-33.6% | -$93.83M-15.0% | -$85.16M-7.2% | -$82.54M-9.0% | -$84.06M-15.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Taysha Gene Therapies, Inc.'s cash flow data come from?
- Every line is extracted from Taysha Gene Therapies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.